Medical Economics October 21, 2024
Key Takeaways
- David Joyner, with extensive healthcare experience, is appointed as CVS Health’s new president and CEO, succeeding Karen Lynch.
- CVS Health is undergoing strategic restructuring, including job cuts and store closures, to adapt to changing consumer habits and industry challenges.
- Despite financial pressures, CVS Health reported increased revenue for the first half of 2024, highlighting a complex financial landscape.
- CVS acknowledges the need to update its pharmacy reimbursement model to better align with evolving consumer expectations and operational costs.
Stores are closing as nation’s largest drug store chain, large-scale competitors adapt to market conditions.
A leader in CVS Health will take the helm of the company as president and CEO.
CVS Health announced David Joyner, a 37-year...